Xenon Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Xenon Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Xenon Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Xenon Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.6M | 78k | 46.06 |
| 2023-09-30 | $2.4M | 69k | 34.16 |
| 2023-06-30 | $1.9M | 53k | 35.79 |
| 2023-03-31 | $1.9M | 53k | 35.79 |
| 2022-12-31 | $1.5M | 39k | 39.43 |
| 2022-09-30 | $1.4M | 38k | 36.10 |
| 2022-06-30 | $819k | 27k | 30.42 |
| 2022-03-31 | $882k | 29k | 30.57 |
| 2021-12-31 | $877k | 28k | 31.24 |
| 2021-06-30 | $5.9M | 319k | 18.62 |
| 2021-03-31 | $6.0M | 335k | 17.90 |
| 2020-12-31 | $5.2M | 338k | 15.38 |
| 2020-09-30 | $4.1M | 368k | 11.07 |
| 2020-06-30 | $4.6M | 365k | 12.54 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas